Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis
This study has been completed.
Study NCT01283698   Information provided by Almirall, S.A.

First Received on January 25, 2011.   Last Updated on March 17, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis Vulgaris
Additional conditions recognized in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
Experimental: LAS 41004 dosage 1
Experimental: LAS 41004 dosage 2
Experimental: LAS 41004 dosage 3
Placebo Comparator: placebo
Reference
Sponsors listed in this trial
Almirall, S.A.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services